the results of this study , in conjunction with other toxicity and efficacy studies , have been utilized to select one of these compounds for development as a replacement for the antimalarial drug primaquine , and also to characterize the mhb-forming properties of wr 6026 .
C0003374
antimalarial drug
C0033126
primaquine